维亚生物授出858万份购股权

Core Viewpoint - Via Biotechnology (01873) announced the granting of stock options to several qualified participants, allowing the subscription of a total of 8.58 million ordinary shares, based on its stock option plan adopted on April 14, 2019 [1] Summary by Relevant Categories - Company Announcement - The company will grant stock options on December 2, 2025, under its stock option plan [1] - A total of 8.58 million ordinary shares will be available for subscription [1]